By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
Life Science Nation (LSN) and the Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP) are announcing a joint event, bringing the SAPA-GP Venture Forum together with the Redefining Early Stage Investments (RESI) conference, taking place at the Convene in Philadelphia on June 3rd, 2019. The combined event will bring the global RESI investor and channel partner network together with the SAPA-GP community, creating a unique conference that is greater than the sum of their parts.
RESI conferences are established go-to events for fundraising CEOs, early-stage investors and channel partners that foster a fit in terms of stage of development and product with vetted investor mandates. RESI provides a matching platform to enable the vital flow of capital from investors and thereby helping emerging life science companies bring their products to market at a faster pace. RESI events are held throughout the year at major innovation hubs around the world.
RESI Philadelphia will feature a SAPA-GP Track with panel discussions, Start-up Roadshows, VC-Startup networking and Open-Table Consultations. RESI attendees will have access to this unique content, while SAPA-GP Venture Forum attendees can take advantage of the RESI panel and workshop tracks, as well as gain access to the unique RESI Partnering Forum.
LSN and SAPA-GP hope to see you at RESI Philadelphia! For any questions about SAPA-Track, please reach out to Candice He at c.he@lifesciencenation.com or WeChat: CandiceHe1028.
About SAPA-GP
Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP) is to serve the fast-growing community of pharmaceutical and biotech professionals in the Greater Philadelphia area. With a significant concentration of global pharmaceutical companies, biotech companies, and academic institutions, the greater Philadelphia area has been a center of life science discoveries and pharmaceutical innovations. Founded in 2002, SAPA-GP has established a broad-based membership and become one of the region’s premier professional organizations. It strives to bring venture investment from the U.S. and China to support the growth of the local life science entrepreneurship.
About Life Science Nation
Life Science Nation (LSN) accelerates fundraising using its matching platform to create highly compatible relationships between early-stage scientists/entrepreneurs and emerging technology investors. LSN researches and curates market intelligence on two industry sectors: The first is emerging biotech and MedTech companies, which by their ephemeral nature are challenging to find and track. Second, LSN tracks ten categories of early-stage life science investors and identifies who is filling the void left by venture capital. LSN owns and operates the Redefining Early Stage Investments (RESI) conference series, which brings together global early-stage biotech and MedTech companies with early-stage investors. Learn more at www.lifesciencenation.com
Next Phase Newsletter 
Leave a comment